Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIER3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ATPIF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACTR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRSF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IER3IP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATMIN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SS18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD164 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MC1R - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPT7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAPG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RC3H2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPAP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VPS4B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARF6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAPD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BCAP29 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADAM9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SFPQ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on